/PRNewswire/ Lykan Bioscience, an innovative contract development and manufacturing organization (CDMO) focused on cell-based therapies, today welcomes.
/PRNewswire/ Lykan Bioscience and RoslinCT, a leader in Contract Development and Manufacturing for cell therapies, announced the formation of its inaugural.
Published: Apr 01, 2021
HOPKINTON, Mass., April 1, 2021 /PRNewswire/ Lykan Bioscience, a contract development and manufacturing services organization and provider of the first true end-to-end solution for the manufacture of cell-based therapies, today announced the appointment of Patrick Lucy as its President & Chief Executive Officer, effective April 1, 2021. Patrick will assume day-to-day leadership of the Company and will also join Lykan s Board of Directors. Anthony Rotunno, Lykan s current CEO, will assume the role of Founder & Executive Vice Chairman and will continue to contribute to the growth of the Company.
Patrick Lucy becomes President and Chief Executive Officer Anthony Rotunno assumes role of Founder and Executive Vice Chair